52 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
,” “Composition & Structure,” “Processes & Practices,” “Management Oversight,” and “Board Culture and Dynamics” as key evaluation items, and Directors were also … requested to make self-evaluations about the “Oversight by ASC and Nomination Committee.” After incorporating the analysis and recommendations made
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
& Practices,” “Management Oversight,” and “Board Culture and Dynamics” as key evaluation items, and Directors were also requested to make self … -evaluations about the “Oversight by ASC and Nomination Committee.” After incorporating the analysis and recommendations made by the third-party organization
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
oversight to ensure we execute a sound strategy, monitor and address risks, and instill effective governance for Takeda to create long-term value for its … , with oversight from the Board of Directors. Principal enterprise risks and their mitigation effectiveness are approved by the Risk, Ethics
S-8
EX-99.2
TAK
Takeda Pharmaceutical Co
28 Jun 23
Registration of securities for employees
6:35am
and oversight of the Takeda ESPP, as well as the authority to designate any Group Company as a Participating Group Company for purposes of the Takeda ESPP
6-K
EX-99.1
wyac9ep583
23 Jun 23
Current report (foreign)
6:13am
6-K
x0ngdysr
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
5ygybb
30 May 23
Current report (foreign)
6:11am
6-K
cdx9fh 5m
11 Jul 22
Current report (foreign)
6:05am
6-K
e6e2t
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
yu0e5ns
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
080v9nkpt4av78
31 May 22
Current report (foreign)
12:00am
6-K
ycvza
1 Apr 22
Current report (foreign)
6:14am
6-K
d70bd
22 Mar 22
Current report (foreign)
6:13am
6-K
ocg1t5 iprgncsrz
1 Nov 21
Current report (foreign)
6:04am
6-K
mjhrwwpcpmz59hlehxfq
6 Aug 21
Current report (foreign)
6:10am
6-K
c344gk9
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
fn0iobgr
29 Jun 21
Current report (foreign)
7:38am